<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="14160">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00328042</url>
  </required_header>
  <id_info>
    <org_study_id>IAC 05-067</org_study_id>
    <nct_id>NCT00328042</nct_id>
  </id_info>
  <brief_title>Hepatitis C Self-Management</brief_title>
  <official_title>A Self-Management Intervention for Veterans With Hepatitis C</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to compare the efficacy of a 6-session hepatitis C
      self-management workshop to a hepatitis C self-management self-study program. Both
      interventions are designed to help people with hepatitis C learn to actively self-manage
      their chronic HCV infection, and ultimately, to improve health outcomes for veterans with
      HCV who are not receiving Interferon-based treatment. Participants complete a total of four
      assessments. The fourth assessment, a 12-18 month assessment is an approved addition to the
      original study design
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Chronic hepatitis C (HCV) is a major health concern that disproportionately
      affects U.S. veterans. Veterans with HCV experience impaired quality of life as a result of
      HCV infection and other co-morbid disorders; namely substance abuse and mental health
      problems. Only a small proportion of these patients currently receive and are cured of HCV
      with Interferon-based treatments. Treatment recommendations for HCV-infected veterans not
      scheduled for Interferon-based treatment include additional evaluations/procedures and
      adherence to behavioral/lifestyle guidelines. However, many patients with HCV and commonly
      occurring co-morbidities have difficulty following these recommendations without additional
      assistance. HCV self-management programs are one option for helping these patients adhere to
      treatment recommendations while improving their quality of life. Patient self-management
      programs augment traditional information-oriented patient education with problem-solving
      skills and cognitive-behavioral techniques that enable patients to manage chronic illness
      and their lives as a whole.

      Objectives: Our primary objective was to assess the efficacy of a 6-session self-management
      workshop designed to improve health outcomes for veterans with HCV who are not receiving
      Interferon-based treatment.

      Methods: One hundred- thirty seven Veterans with HCV who receive health care at VA San Diego
      Healthcare System facilities were randomized to either the HCV Self-Management Workshop
      (HCV-SMW) or to the Information intervention study arm. The self-management intervention
      includes six 2.5-hour weekly workshop sessions in addition to the basic information provided
      to Usual Care. The HCV-SMW was co-led by a health educator and a peer-leader, and has been
      adapted from an existing self-management program that has been effective for patients with
      other chronic illnesses. The primary outcome for the study is health-related quality of
      life. Secondary outcome variables include attendance at recommended health care visits,
      self-reported health behaviors related to preventing viral transmission, substance
      use/abuse, and patient-provider communication. Data was collected at baseline,
      end-of-intervention (6 weeks), at a 12-month and 18-month follow-up visits using self-report
      questionnaires. In accordance with HIPAA guidelines, VA medical records and other databases
      were accessed to gather data on health care utilization and mortality. Data was analyzed
      using repeated-measures analysis of variance, ANCOVA, and linear mixed-model approaches. In
      addition, an exploratory cost analysis will be conducted when final analyses are conducted.

      Status: The study was completed in 2011. Results have been published and citations are
      provided on this website. An additional manuscript including a cost-effectiveness analysis
      is in the process of being published.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>Quality of Well-being Scale - Self-Administered (QWB-SA)</measure>
    <time_frame>Base Line, 12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The QWB-SA is a preference-based measure of health-related quality of life. Scores range from 0 to 1.0, with 0 representing death, and 1.0 representing asymptomatic, optimal functioning. Thus, higher scores indicate higher quality of life.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hepatitis C Knowledge Questionnaire</measure>
    <time_frame>Base Line, 6 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>The measure consists of 15 questions covering Hepatitis C-specific information related to disease self-management. Each correct response is scored as one point, with total scores range from 0 to 15. Higher scores indicate higher levels of Hepatitis C-specific knowledge. There are no subscales.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">134</enrollment>
  <condition>Hepatitis C</condition>
  <condition>Chronic Disease</condition>
  <arm_group>
    <arm_group_label>Self-Management Workshop</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Information Only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Self-Management Workshop</intervention_name>
    <description>The workshop is a once per week 2.5 hour group that meets for six weeks.</description>
    <arm_group_label>Self-Management Workshop</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Information Only</intervention_name>
    <description>This is an individual self-paced at home study program.</description>
    <arm_group_label>Information Only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  VA patient

          -  Diagnosis of chronic hepatitis C viral infection

        Exclusion Criteria:

          -  Undergoing treatment with Interferon and/or Ribavirin currently or within 6 months of
             enrollment

          -  Inability to confirm HCV diagnosis
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erik J Groessl, PhD BA BS</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA San Diego Healthcare System, San Diego, CA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA San Diego Healthcare System, San Diego, CA</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92161</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Groessl EJ, Weingart KR, Stepnowsky CJ, Gifford AL, Asch SM, Ho SB. The hepatitis C self-management programme: a randomized controlled trial. J Viral Hepat. 2011 May;18(5):358-68. doi: 10.1111/j.1365-2893.2010.01328.x.</citation>
    <PMID>20529203</PMID>
  </results_reference>
  <results_reference>
    <citation>Groessl EJ, Weingart KR, Gifford AL, Asch SM, Ho SB. Development of the hepatitis C self-management program. Patient Educ Couns. 2011 May;83(2):252-5. doi: 10.1016/j.pec.2010.06.006. Epub 2010 Jul 17.</citation>
    <PMID>20638216</PMID>
  </results_reference>
  <results_reference>
    <citation>Dieperink E, Ho SB, Heit S, Durfee JM, Thuras P, Willenbring ML. Significant reductions in drinking following brief alcohol treatment provided in a hepatitis C clinic. Psychosomatics. 2010 Mar-Apr;51(2):149-56. doi: 10.1176/appi.psy.51.2.149.</citation>
    <PMID>20332290</PMID>
  </results_reference>
  <results_reference>
    <citation>Pichetshote N, Groessl E, Yee H, Ho SB. Optimizing the dose and duration of therapy for chronic hepatitis C. Gut Liver. 2009 Mar;3(1):1-13. doi: 10.5009/gnl.2009.3.1.1. Epub 2009 Mar 31.</citation>
    <PMID>20479894</PMID>
  </results_reference>
  <results_reference>
    <citation>Groessl EJ, Weingart KR, Kaplan RM, Clark JA, Gifford AL, Ho SB. Living with hepatitis C: qualitative interviews with hepatitis C-infected veterans. J Gen Intern Med. 2008 Dec;23(12):1959-65. doi: 10.1007/s11606-008-0790-y. Epub 2008 Sep 20.</citation>
    <PMID>18807097</PMID>
  </results_reference>
  <results_reference>
    <citation>Groessl EJ, Ho SB, Asch SM, Stepnowsky CJ, Laurent D, Gifford AL. The hepatitis C self-management program: sustainability of primary outcomes at 1 year. Health Educ Behav. 2013 Dec;40(6):730-40. doi: 10.1177/1090198113477112. Epub 2013 Feb 27.</citation>
    <PMID>23445604</PMID>
  </results_reference>
  <verification_date>July 2014</verification_date>
  <lastchanged_date>April 6, 2015</lastchanged_date>
  <firstreceived_date>May 17, 2006</firstreceived_date>
  <firstreceived_results_date>August 26, 2014</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Self-care</keyword>
  <keyword>Quality of Life</keyword>
  <keyword>Chronic disease</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Chronic Disease</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Self-Management Workshop</title>
          <description>Self-Management Workshop: In addition to receiving HCV information materials to take home, the in-person 2.5 hour group workshop occurs weekly for six weeks.</description>
        </group>
        <group group_id="P2">
          <title>Information Only</title>
          <description>Information Only: This group receives a Hepatitis C Information Booklet and an HCV Resource Guide. The materials are designed for individual self-study.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="69"/>
                <participants group_id="P2" count="65"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="69"/>
                <participants group_id="P2" count="63"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Arm 1</title>
          <description>Self-Management Workshop: The workshop is a once per week 2.5 hour group that meets for six weeks.</description>
        </group>
        <group group_id="B2">
          <title>Arm 2</title>
          <description>Self-management self-study: This is an individual self-paced at home study program.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="69"/>
                <measurement group_id="B2" value="65"/>
                <measurement group_id="B3" value="134"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="53.0" spread="5.2"/>
                <measurement group_id="B2" value="56.4" spread="7.2"/>
                <measurement group_id="B3" value="54.6" spread="6.2"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="2"/>
                <measurement group_id="B2" value="2"/>
                <measurement group_id="B3" value="4"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="67"/>
                <measurement group_id="B2" value="63"/>
                <measurement group_id="B3" value="130"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>American Indian or Alaska Native</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="2"/>
                <measurement group_id="B3" value="2"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Asian</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="1"/>
                <measurement group_id="B2" value="1"/>
                <measurement group_id="B3" value="2"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Native Hawaiian or Other Pacific Islander</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Black or African American</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="14"/>
                <measurement group_id="B2" value="19"/>
                <measurement group_id="B3" value="33"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>White</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="50"/>
                <measurement group_id="B2" value="42"/>
                <measurement group_id="B3" value="92"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>More than one race</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="4"/>
                <measurement group_id="B2" value="1"/>
                <measurement group_id="B3" value="5"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Unknown or Not Reported</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Hispanic or Latino</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="8"/>
                <measurement group_id="B2" value="5"/>
                <measurement group_id="B3" value="13"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Not Hispanic or Latino</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="61"/>
                <measurement group_id="B2" value="60"/>
                <measurement group_id="B3" value="121"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Unknown or Not Reported</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="69"/>
                <measurement group_id="B2" value="65"/>
                <measurement group_id="B3" value="134"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Quality of Well-being Scale - Self-Administered (QWB-SA)</title>
        <description>The QWB-SA is a preference-based measure of health-related quality of life. Scores range from 0 to 1.0, with 0 representing death, and 1.0 representing asymptomatic, optimal functioning. Thus, higher scores indicate higher quality of life.</description>
        <time_frame>Base Line, 12 months</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Arm 1</title>
            <description>Self-Management Workshop: The workshop is a once per week 2.5 hour group that meets for six weeks.</description>
          </group>
          <group group_id="O2">
            <title>Arm 2</title>
            <description>Self-management self-study: This is an individual self-paced at home study program.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="69"/>
                  <measurement group_id="O2" value="63"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Quality of Well-being Scale - Self-Administered (QWB-SA)</title>
            <description>The QWB-SA is a preference-based measure of health-related quality of life. Scores range from 0 to 1.0, with 0 representing death, and 1.0 representing asymptomatic, optimal functioning. Thus, higher scores indicate higher quality of life.</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>Baseline QWB-SA score</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value=".534" spread=".153"/>
                  <measurement group_id="O2" value=".501" spread=".163"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>12-month QWB-SA score</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value=".600" spread=".170"/>
                  <measurement group_id="O2" value=".504" spread=".152"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hepatitis C Knowledge Questionnaire</title>
        <description>The measure consists of 15 questions covering Hepatitis C-specific information related to disease self-management. Each correct response is scored as one point, with total scores range from 0 to 15. Higher scores indicate higher levels of Hepatitis C-specific knowledge. There are no subscales.</description>
        <time_frame>Base Line, 6 weeks</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Self-Management Workshop</title>
            <description>Self-Management Workshop: In addition to receiving HCV information materials to take home, the in-person 2.5 hour group workshop occurs weekly for six weeks.</description>
          </group>
          <group group_id="O2">
            <title>Information Only</title>
            <description>Information Only: This group receives a Hepatitis C Information Booklet and an HCV Resource Guide. The materials are designed for individual self-study.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="69"/>
                  <measurement group_id="O2" value="63"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Hepatitis C Knowledge Questionnaire</title>
            <description>The measure consists of 15 questions covering Hepatitis C-specific information related to disease self-management. Each correct response is scored as one point, with total scores range from 0 to 15. Higher scores indicate higher levels of Hepatitis C-specific knowledge. There are no subscales.</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>Baseline HCV Knowledge</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="8.74" spread="3.12"/>
                  <measurement group_id="O2" value="8.60" spread="2.71"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>6-weeks HCV Knowledge</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="12.29" spread="2.16"/>
                  <measurement group_id="O2" value="9.92" spread="2.75"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Adverse Events were not monitored for the study as required by the IRB. This was determined because the intervention was considered low risk and consisted of an educational and behavioral change workshop.</desc>
      <group_list>
        <group group_id="E1">
          <title>Self-Management Workshop</title>
          <description>Self-Management Workshop: In addition to receiving HCV information materials to take home, the in-person 2.5 hour group workshop occurs weekly for six weeks.</description>
        </group>
        <group group_id="E2">
          <title>Information-Only</title>
          <description>Information Only: This group receives a Hepatitis C Information Booklet and an HCV Resource Guide. The materials are designed for individual self-study.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Erik Groessl</name_or_title>
      <organization>VA San Diego</organization>
      <phone>858-552-8585</phone>
      <email>erik.groessl@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
